Search research articles
Contact Us
Filters
Showing results (11-20 of 161) with videos related to
Page
of 17
Sort By:
BMJ (Clinical Research Ed.)
|
December 13, 2003
Drug sales in four European countries still differ
Silvio Garattini, Livio Garattini
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 21, 2006
Off-patent drugs in Italy. A short-sighted view?
Livio Garattini, Simone Ghislandi
Pharmacoeconomics
|
December 19, 2019
Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'
Livio Garattini, Nicholas Freemantle
Pharmacoeconomics - Open
|
February 4, 2018
Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 5, 2019
Conflict of interest disclosure: striking a balance?
Livio Garattini, Anna Padula
Postgraduate Medicine
|
November 1, 2017
Pharmaceutical care in Italy and other European countries: between care and commerce?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
September 6, 2017
Immunotherapies for advanced melanoma: as promising as they are expensive?
Livio Garattini, Anna Padula
Applied Health Economics and Health Policy
|
August 20, 2017
Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?
Livio Garattini, Anna Padula
Pharmacoeconomics
|
June 5, 2016
Performance-Based Agreements in Italy: 'Trendy Outcomes' or Mere Illusions?
Livio Garattini, Alessandro Curto
Applied Health Economics and Health Policy
|
August 16, 2014
Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Alessandro Curto, Livio Garattini
Page
of 17
Search research articles
Search
Showing results (11-20 of 161) with videos related to
Sort By:
Page
of 17
BMJ (Clinical Research Ed.)
|
December 13, 2003
Drug sales in four European countries still differ
Silvio Garattini, Livio Garattini
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 21, 2006
Off-patent drugs in Italy. A short-sighted view?
Livio Garattini, Simone Ghislandi
Pharmacoeconomics
|
December 19, 2019
Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'
Livio Garattini, Nicholas Freemantle
Pharmacoeconomics - Open
|
February 4, 2018
Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?
Livio Garattini, Anna Padula
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 5, 2019
Conflict of interest disclosure: striking a balance?
Livio Garattini, Anna Padula
Postgraduate Medicine
|
November 1, 2017
Pharmaceutical care in Italy and other European countries: between care and commerce?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
September 6, 2017
Immunotherapies for advanced melanoma: as promising as they are expensive?
Livio Garattini, Anna Padula
Applied Health Economics and Health Policy
|
August 20, 2017
Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?
Livio Garattini, Anna Padula
Pharmacoeconomics
|
June 5, 2016
Performance-Based Agreements in Italy: 'Trendy Outcomes' or Mere Illusions?
Livio Garattini, Alessandro Curto
Applied Health Economics and Health Policy
|
August 16, 2014
Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Alessandro Curto, Livio Garattini
Page
of 17